STOCK COMMENTS/EPS CHANGES
price target was boosted at Miller Tabak. Shares are now seen reaching $400. Company should benefit from Qdoba closures, Miller Tabak said. Buy rating.
estimates were raised at Citigroup for 2014. Volume supports the low end of fourth-quarter guidance and a fuel benefit, said Citi.
price target and estimates were raised at BMO Capital. Earnings estimates were increased as high single-digit sales growth will be driven by the premium segment and organic opportunities, said BMO Capital. Price target is $69.
price target and estimates were raised at Cantor Fitzgerald. Reflect accelerated growth from generics and market share gains, said Cantor Fitzgerald. Price target goes to $33.
was added to US 1 List at Bank of America/Merrill Lynch. Cash flow can double over the next five years, BofA/Merrill said. $200 price target.
price target was raised at Oppenheimer. Shares are now seen reaching $85. Recent channel checks have been encouraging, Oppenheimer said. Outperform rating.
price target, earnings estimates were reduced at BMO Capital. Shares kept their outperform rating despite lowered EPS estimates and a new $36 price target, BMO Capital Markets said. Management blames weakness in European housing sector, BMO also said.
price target was boosted at Deutsche Bank. Shares are now seen reaching $63. Company is being cautious about 2014 Medicare changes but maintains a strong long-term industry position, Deutsche said. Hold rating.
was cut from Conviction Buy List at Goldman Sachs. $40 price target. Geismar outage likely will hurt earnings, Goldman Sachs said.
>To submit a news tip, email:
and become a fan on